Bladder cancer is typically characterized by the reduced expression of the cell adhesion molecule E‐cadherin with grade and stage progression, and elevated expression of N‐ or P‐cadherin within muscle‐invasive tumors. This evidence concerns the gene CDH1 and urinary bladder carcinoma.